CXC chemokine ligand 12/stromal cell-derived factor-1 regulates cell adhesion in human colon cancer cells by induction of intercellular adhesion molecule-1. 2012

Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
Department of Hepato-Gastroenterology, Chang Gung Memorial Hospital, Chiayi, Taiwan.

BACKGROUND The CXC chemokine ligand 12 (CXCL12)/stromal cell-derived factor-1 (SDF-1) and CXC receptor 4 (CXCR4) axis is involved in human colorectal cancer (CRC) carcinogenesis and can promote the progression of CRC. Interaction between CRC cells and endothelium is a key event in tumor progression. The aim of this study was to investigate the effect of SDF-1 on the adhesion of CRC cells. METHODS Human CRC DLD-1 cells were used to study the effect of SDF-1 on intercellular adhesion molecule-1 (ICAM-1) expression and cell adhesion to endothelium. RESULTS SDF-1 treatment induced adhesion of DLD-1 cells to the endothelium and increased the expression level of the ICAM-1. Inhibition of ICAM-1 by small interfering RNA (siRNA) and neutralizing antibody inhibited SDF-1-induced cell adhesion. By using specific inhibitors and short hairpin RNA (shRNA), we demonstrated that the activation of ERK, JNK and p38 pathways is critical for SDF-1-induced ICAM-1 expression and cell adhesion. Promoter activity and transcription factor ELISA assays showed that SDF-1 increased Sp1-, C/EBP-β- and NF-κB-DNA binding activities in DLD-1 cells. Inhibition of Sp1, C/EBP-β and NF-κB activations by specific siRNA blocked the SDF-1-induced ICAM-1 promoter activity and expression. The effect of SDF-1 on cell adhesion was mediated by the CXCR4. CONCLUSIONS Our findings support the hypothesis that ICAM-1 up-regulation stimulated by SDF-1 may play an active role in CRC cell adhesion.

UI MeSH Term Description Entries
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D004727 Endothelium A layer of epithelium that lines the heart, blood vessels (ENDOTHELIUM, VASCULAR), lymph vessels (ENDOTHELIUM, LYMPHATIC), and the serous cavities of the body. Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D054377 Chemokine CXCL12 A CXC chemokine that is chemotactic for T-LYMPHOCYTES and MONOCYTES. It has specificity for CXCR4 RECEPTORS. Two isoforms of CXCL12 are produced by alternative mRNA splicing. CXCL12 Chemokine,Stromal Cell-Derived Factor-1beta,Chemokine (C-X-C Motif) Ligand 12,Pre-B-Cell Growth-Stimulating Factor,SDF-1alpha,SDF-1beta,SDF1-3'A,Stromal Cell-Derived Factor 1,Stromal Cell-Derived Factor-1alpha,CXCL12, Chemokine,Cell-Derived Factor-1beta, Stromal,Chemokine, CXCL12,Growth-Stimulating Factor, Pre-B-Cell,Pre B Cell Growth Stimulating Factor,SDF 1alpha,SDF 1beta,SDF1 3'A,Stromal Cell Derived Factor 1,Stromal Cell Derived Factor 1alpha,Stromal Cell Derived Factor 1beta
D061307 Human Umbilical Vein Endothelial Cells Endothelial cells that line venous vessels of the UMBILICAL CORD. Human Umbilical Vein Endothelial Cell,Endothelial Cells, Human Umbilical Vein,HUVEC Cells,Cell, HUVEC,Cells, HUVEC,HUVEC Cell
D018799 Intercellular Adhesion Molecule-1 A cell-surface ligand involved in leukocyte adhesion and inflammation. Its production is induced by gamma-interferon and it is required for neutrophil migration into inflamed tissue. Antigens, CD54,CD54 Antigens,ICAM-1,CD54 Antigen,Antigen, CD54,Intercellular Adhesion Molecule 1

Related Publications

Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
September 2007, Journal of immunology (Baltimore, Md. : 1950),
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
May 2005, Journal of immunology (Baltimore, Md. : 1950),
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
November 2001, The Journal of biological chemistry,
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
July 2004, Biochemical and biophysical research communications,
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
December 2003, Laboratory investigation; a journal of technical methods and pathology,
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
August 1995, Journal of cellular physiology,
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
January 2007, Molecular cancer research : MCR,
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
April 1997, Journal of immunology (Baltimore, Md. : 1950),
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
April 1997, Annals of the New York Academy of Sciences,
Shui-Yi Tung, and Shun-Fu Chang, and Ming-Hui Chou, and Wen-Shih Huang, and Yung-Yu Hsieh, and Chien-Heng Shen, and Hsing-Chun Kuo, and Cheng-Nan Chen
May 2003, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!